Bausch Expects US Approval In 2020 Of Preservative-Free OTC Ketotifen Eye Drop

Bausch says it expects US FDA to approve its ANDA for the first preservative-free OTC eye drop for ocular itching associated with allergic conjunctivitis in the second half of 2020. The firm reports its Lumify redness relief drops generated sales of $63m for 2019.

Eye

Bausch Health Companies Inc. expects US approval during the second half of 2020 of its application for the first preservative-free OTC eye drop containing ketotifen for the treatment of itching associated with allergic conjunctivitis.

Bausch submitted to the Food and Drug Administration an abbreviated new drug application for OTC use of preservative-free ketotifen, identified...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Canada

More from North America